vTv Therapeutics Inc.

NASDAQ: VTVT · Real-Time Price · USD
15.11
1.08 (7.70%)
At close: Aug 14, 2025, 3:58 PM
15.31
1.32%
After-hours: Aug 14, 2025, 04:10 PM EDT

vTv Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.02M n/a 2.02M 4M
Cost of Revenue
89K 90K 92K 89K
Gross Profit
928K -90K 1.93M 3.92M
Operating Income
-24.18M -25.5M -22.54M -21.66M
Interest Income
1.56M 472K 352K 1K
Pretax Income
-22.61M -25.97M -24.87M -17.62M
Net Income
-18.46M -20.25M -19.16M -12.99M
Selling & General & Admin
13.65M 11.91M 12.2M 12.34M
Research & Development
11.55M 13.51M 12.36M 13.32M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
25.2M 25.41M 24.56M 25.67M
Interest Expense
n/a 13K 15K 12K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
25.2M 25.5M 24.56M 25.67M
Income Tax Expense
100K n/a 200K 115K
Shares Outstanding (Basic)
5.77M 2.08M 1.92M 1.57M
Shares Outstanding (Diluted)
5.77M 2.08M 1.92M 1.57M
EPS (Basic)
-3.2 -9.71 -9.98 -8.29
EPS (Diluted)
-3.2 -9.71 -9.98 -8.29
EBITDA
-22.52M -25.86M -24.77M -17.52M
EBIT
-22.61M -25.95M -24.86M -17.6M
Depreciation & Amortization
89K 90K 92K 89K